Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerosis
An update on a clinical trial evaluating the effect and efficacy of the Xpedition/Alpine everolimus-eluting stent for coronary atheroscleros…
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.) [NA]
The F.A.M.E. trial comparing fractional flow reserve (FFR) versus angiography for multivessel evaluation in coronary artery disease has comp…
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents [Phase 4]
Phase 4 trial update evaluating neointimal coverage after implantation of a Biolimus-eluting stent with biodegradable polymer. The study use…
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Fractional Flow Reserve Versus Angiography for Guiding Selective Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction
An update on a clinical trial comparing fractional flow reserve-guided PCI with angiography in ST-segment elevation myocardial infarction, w…
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Myocardial Flow Reserve and 99mTc-DTPA Cardiac Dynamic SPECT [NA]
This is a clinical trial update about evaluating myocardial flow reserve using 99mTc-DTPA cardiac dynamic SPECT in patients with coronary ar…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-07-22FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for BRILINTA (ticagrelor) submitted by AstraZeneca Pharmaceuticals LP. The action concerns a supplem…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Spinal Anesthesia Associated With General Anesthesia in Coronary Artery Bypass [Phase 4]
This Phase 4 trial update assesses the outcomes of adding spinal anesthesia to general anesthesia for patients undergoing coronary artery by…
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: XIENCE PRIME Japan Post-Marketing Surveillance (PMS)
Post-marketing surveillance update for XIENCE PRIME in Japan; study completed with results posted in 2016.
-
CLINICAL_TRIALS research · 2016-07-18Clinical Trial Update: REPARA Study: REgistry of PAtients With bioResorbable Device in Daily Clinical prActice
This document describes the REPARA registry, which collects data on patients treated with bioresorbable coronary devices in daily clinical p…
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) [Phase 3]
Phase 3 trial evaluating ranolazine for incomplete vessel revascularization after PCI in people with coronary artery disease and angina; the…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: OPtical Frequency Domain Imaging Versus INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging [Phase 3]
A Phase 3 trial comparing optical frequency domain imaging (OFDI) with intravascular ultrasound (IVUS) in percutaneous coronary intervention…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON [Phase 3]
A Phase 3 trial comparing Optical Frequency Domain Imaging (OFDI) with Intravascular Ultrasound (IVUS) to guide percutaneous coronary interv…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: REWARDS Premier Taxus-Liberte vs Xience V
A completed clinical trial comparing Taxus Liberte drug-eluting stents with Xience V drug-eluting stents in patients with coronary artery di…
-
CLINICAL_TRIALS research · 2016-07-13Clinical Trial Update: Evaluation of Emotional Status and Coronary Flow Characteristics by TIMI Frame Count Method [NA]
Clinical trial update evaluating how emotional status (anxiety and depression) relates to coronary flow characteristics measured by the TIMI…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Beta-Blocker Heart Attack Trial (BHAT) [Phase 3]
This update reports the completion of the Phase 3 Beta-Blocker Heart Attack Trial (BHAT), a study of beta-blocker therapy in patients after …
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART) [Phase 3]
A phase 3 clinical trial (WELL-HART) evaluating estrogen/progestin therapy for lipid lowering and regression of atherosclerosis has complete…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Multicenter Investigation of Limitation of Infarct Size (MILIS) [Phase 3]
Phase 3 multicenter trial MILIS evaluating strategies to limit infarct size in myocardial infarction has completed enrollment and is reporte…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Women's Angiographic Vitamin and Estrogen Trial (WAVE) [Phase 3]
Phase 3 trial in postmenopausal women evaluating estrogen plus a vitamin treatment for cardiovascular outcomes has completed.
-
CLINICAL_TRIALS research · 2016-07-12Clinical Trial Update: Identification of Genes Predisposing to Atherosclerosis
Updates on a completed clinical trial that sought to identify genetic factors predisposing to atherosclerosis, with the goal of uncovering g…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Genetics of Atherosclerosis in Mexican Americans
NHLBI-sponsored study on the genetics of atherosclerosis in Mexican Americans; status is COMPLETED. The study focused on cardiovascular cond…
-
CLINICAL_TRIALS research · 2016-07-12Clinical Trial Update: Behavioral and Immunological Factors in Coronary Disease
The NHLBI-sponsored trial investigated behavioral and immunological factors in coronary disease, and the study status is completed.
-
CLINICAL_TRIALS research · 2016-07-12Clinical Trial Update: Assessment Of Total Coronary Circulation Time Using TIMI Frame Count Method (TCCT-TIMI) [NA]
Clinical trial update evaluating total coronary circulation time using the TIMI frame count method (TCCT-TIMI) in coronary artery-related co…
-
CLINICAL_TRIALS research · 2016-07-12Clinical Trial Update: 20 Year Changes in Fitness & Cardiovascular Disease Risk - Ancillary to CARDIA
This NHLBI-funded ancillary CARDIA study has completed and reports on 20-year changes in fitness and cardiovascular risk, with observations …
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or Famotidine [Phase 4]
A Phase 4 study evaluated whether concomitant treatment with omeprazole, pantoprazole, or famotidine alters clopidogrel’s platelet inhibitor…
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Single-centre, Registry Trial, the Patients Presented With Stable Coronary Artery Disease
This entry notes the completion of a single-centre registry trial in patients with stable coronary artery disease and indicates that results…